Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Cureus ; 16(4): e58354, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38756316

RESUMEN

Black hairy tongue (BHT) is a lesion in which the filiform papillae of the tongue are significantly extended by hyperkeratosis, thereby giving the tongue a hairy appearance. Here, we report two rare cases of children with BHT and tooth discoloration caused by antimicrobial agents. Case 1: A four-year-old female patient received intravenous linezolid after spinal surgery, and BHT developed on day eight of treatment. Subsequently, the patient developed teeth discoloration. Linezolid was continually administered for 50 days, and BHT and teeth discoloration improved 10 days after the end of linezolid treatment. Case 2: A two-year-old male patient with a brain abscess received intravenous meropenem and vancomycin. On the fourth day of treatment, BHT developed, and teeth discoloration was subsequently observed. Antibiotic therapy was continued for 82 days, and BHT and tooth discoloration improved 20 days after the treatment was discontinued.

2.
J Infect Chemother ; 30(2): 176-178, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37769991

RESUMEN

There are few reports on the association between antipyretic use and antibody titers in adolescents and young adults following SARS-CoV-2 vaccination. Multivariable linear regression analyses were performed to examine the association between antipyretic use and antibody titers. The use of antipyretics was not associated with antibody titers (ß coefficient [95% CI] = -0.107 [-0.438 to 0.224]).


Asunto(s)
Antipiréticos , COVID-19 , Adolescente , Adulto Joven , Humanos , Vacunas contra la COVID-19 , Vacuna BNT162 , COVID-19/prevención & control , SARS-CoV-2 , Anticuerpos Antivirales
3.
J Infect Chemother ; 29(1): 61-66, 2023 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36152928

RESUMEN

BACKGROUND: Data are limited regarding the safety of and antibody response to the BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid vaccine in adolescents and young adults with underlying disease. METHODS: This prospective observational study enrolled patients age 12-25 years with chronic underlying disease who received 2 doses of BNT162b2. A 18-item questionnaire was used to assess adverse events within 7 days post-vaccination, and data regarding severe adverse events were collected from electronic medical records. An antibody titer for the receptor-binding domain of the spike protein in SARS-CoV-2 was used to assess antibody response after the second vaccine dose. RESULTS: Study participants were 429 patients (241 [56.2%] age 12-15 years; 188 [43.8%] age 16-25 years). The most common underlying diseases were genetic or chromosomal abnormalities and/or congenital anomalies, followed by endocrine or metabolic diseases; 32% of participants were immunocompromised. Severe adverse events were observed after the second dose in 1 (0.4%) patient age 12-15 years and in 2 (1.1%) patients age 16-25 years; all patients recovered. Seropositivity after the second vaccine dose was 99.0%. The geometric mean antibody titer was higher in patients age 12-15 years versus 16-25 years (1603.3 [1321.8-1944.7] U/mL vs. 949.4 [744.2-1211.0] U/mL). Compared with immunocompetent patients, immunocompromised patients had a lower antibody titer (2106.8 [1917.5-2314.7] U/mL vs. 467.9 [324.4-674.8] U/mL). CONCLUSIONS: Vaccination with BNT162b2 was acceptably safe and immunogenic for adolescents and young adults with underlying disease.


Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , SARS-CoV-2 , Adolescente , Adulto , Niño , Humanos , Adulto Joven , Anticuerpos Antivirales , Formación de Anticuerpos , Vacuna BNT162 , COVID-19/prevención & control , Vacunas contra la COVID-19/efectos adversos
4.
J Infect Chemother ; 28(8): 1168-1171, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-35370079

RESUMEN

A neonatal patient with Herpes simplex virus type-2 meningoencephalitis was treated by high-dose intravenous acyclovir therapy. Serum and cerebrospinal fluid (CSF) concentrations were measured retrospectively, showing that the CSF-to-serum concentration ratio was 0.67-0.71, which was higher than the previously reported values in other age groups.


Asunto(s)
Herpes Simple , Meningoencefalitis , Aciclovir/uso terapéutico , Antivirales/uso terapéutico , Líquido Cefalorraquídeo , Herpes Simple/tratamiento farmacológico , Herpesvirus Humano 2 , Humanos , Recién Nacido , Meningoencefalitis/tratamiento farmacológico , Estudios Retrospectivos
5.
J Infect Chemother ; 25(5): 368-370, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30686700

RESUMEN

The significance of anaerobic bacteria as a pathogen in urinary tract infection (UTI) in children is unclear. A two-month-old infant presenting with poor feeding received a diagnosis of polymicrobial anaerobic UTI by next-generation sequencing and was found to have obstructive uropathy. Anaerobic bacteria may be a cause of UTI in children with urinary tract obstruction.


Asunto(s)
Antibacterianos/uso terapéutico , Bacterias Anaerobias/aislamiento & purificación , Prevotella melaninogenica/aislamiento & purificación , Pionefrosis/microbiología , Infecciones Urinarias/microbiología , Quimioterapia Combinada , Femenino , Humanos , Lactante , Pionefrosis/diagnóstico por imagen , Pionefrosis/terapia , Pionefrosis/orina , Resultado del Tratamiento , Ultrasonografía , Cateterismo Urinario , Infecciones Urinarias/diagnóstico por imagen , Infecciones Urinarias/terapia , Infecciones Urinarias/orina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...